心臟再同步治疗 (CRT) 设备的全球市场

Cardiac Resynchronization Therapy (CRT) Devices

出版日期: 2024年09月01日 | 出版商:

Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球心臟再同步治疗 (CRT) 设备市场预计将达到 109 亿美元

心臟再同步治疗 (CRT) 设备的全球市场预计 2023 年为 65 亿美元，预计到 2030 年将达到 109 亿美元，在 2023-2030 年分析期间复合年增长率为 7.7%。 CRT心臟去颤器（CRT-D）是本报告分析的细分市场之一，复合年增长率为7.4%，预计到分析期结束时将达到78亿美元。在分析期间，CRT心律调节器(CRT-P) 细分市场的复合年增长率预计为 8.4%。

美国市场预估成长18亿美元，中国复合年增长率7.3%

预计 2023 年美国心臟再同步治疗 (CRT) 设备市场规模将达 18 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达17亿美元，2023-2030年分析期间复合年增长率为7.3%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间复合年增长率分别为 7.0% 和 6.6%。在欧洲，德国预计复合年增长率为 7.2%。

全球心臟再同步治疗 (CRT) 设备市场 - 主要趋势和驱动因素总结

什么是心臟再同步治疗 (CRT) 设备？

心臟再同步治疗 (CRT) 设备是治疗心臟衰竭的重要工具，特别是对于患有电传导障碍、损害心臟有效跳动能力的患者。这些设备旨在恢復心室的协调收缩并提高整体帮浦效率。 CRT 机器通常由心律调节器或植入式心臟整流去颤器(ICD) 组成，其导线放置在心臟的两个心室中。透过向心室发送同步电脉衝，CRT 机器可以纠正心臟衰竭或束支传导阻滞患者常见的心率失调。这种治疗方法通常用于对常规治疗方法没有充分反应的中度至重度心臟衰竭患者。 CRT的最终目标是减少呼吸急促和疲劳等心臟衰竭症状，提高生活质量，并降低住院和死亡风险。心臟衰竭影响全世界数百万人，CRT 设备是治疗这种慢性且常常使人衰弱的疾病的重要介入措施。

哪些技术可以提高 CRT 设备的效率？

CRT 设备的技术进步显着提高了其有效性、安全性和整体患者体验。该领域的主要进展之一是自适应 CRT 系统的开发，该系统可根据患者的活动水平和心律自动调整起搏。这些系统利用复杂的演算法，透过在各种条件下（包括休息时和运动时）使心跳尽可能高效来优化治疗。另一项重大创新是远端监控功能的集成，允许将患者资料即时传输给医疗保健提供者。这使得临床医生能够持续监测设备性能和患者心臟状态，而无需频繁就诊。远端监控不仅可以透过及时协调治疗来改善患者的治疗效果，还可以减少住院和紧急介入的需要。此外，CRT 机器的小型化使其侵入性更小，患者更舒适。这些小型、高效的设备具有更长的电池寿命，并且更容易植入，从而降低了手术期间出现併发症的风险。 CRT 设备中的无线技术允许设备和外部监测系统之间的无缝通讯，进一步改善患者照护。随着技术的进步，CRT 设备在心臟衰竭治疗中的准确性和有效性有望提高，从而为患者带来更好的治疗结果。

心臟再同步治疗设备的主要市场趋势是什么？

心臟再同步治疗设备市场是由技术进步、人口变化和医疗保健服务变化所形成的几个关键趋势所推动的。最显着的趋势之一是全球心臟衰竭盛行率不断增加。这主要是由于人口老化和导致心臟衰竭的疾病发生率不断增加，例如高血压、糖尿病和冠状动脉疾病。因此，对 CRT 设备作为对单独药物治疗没有反应的患者的治疗选择的需求正在增加。另一个主要趋势是越来越多地采用远端患者监护解决方案。随着医疗保健系统不断成为数位平台，具有远端监控功能的 CRT 设备变得越来越普遍。这不仅改善了患者管理，而且符合远端医疗和居家医疗的全球趋势。此外，CRT 设备的小型化和无引线版本正在被开拓，透过降低设备的侵入性并减少与引线相关的併发症的可能性，有望彻底改变市场。这些创新设备的监管核准正在加速，特别是在北美和欧洲等已开发地区，监管机构正在简化流程，以便更快为患者提供救生技术。最后，一些地区扩大医疗保险覆盖范围和报销政策，使 CRT 设备更容易获得并受到更多患者的欢迎。

CRT设备市场扩大背后的因素有哪些？

心臟再同步治疗设备市场的成长是由与技术进步、不断变化的医疗保健趋势和不断变化的患者人口统计相关的几个关键因素所推动的。一个主要驱动因素是全球整体心臟衰竭盛行率不断上升，特别是随着人口老化。随着心臟衰竭患者数量的不断增加，对 CRT 等有效治疗方案的需求也在增加，这对于对传统心臟衰竭治疗没有反应的患者尤其重要。 CRT技术的不断进步，包括自适应CRT设备的开发和远端监控功能的集成，显着增加了这些设备的吸引力。自适应系统可根据患者的特定需求自动调整起搏参数，进而提高治疗效果并降低併发症的可能性。此外，远端医疗和远端患者监护的普及正在推动对能够无缝传输资料的 CRT 设备的需求，从而能够更主动、更有效率地管理心臟衰竭患者。 COVID-19 大流行进一步加速了向居家医疗的转变，凸显了远端监测在慢性病管理中的重要性。另一个驱动因素是越来越多地关注减少再入院和改善长期结果，以及医疗保健系统采用基于价值的照护模式。 CRT 可以改善心臟功能并减少紧急干预的需要，从而满足了这些医疗保健目标。此外，更小的设备尺寸和更长的电池寿命使 CRT 设备更易于使用、侵入性更小、更耐用，从而提高了患者满意度和整体采用率。最后，有利的监管政策和医疗保险的扩张，特别是在新兴市场，正在促进患者获得救生设备，进一步推动市场成长。

受访企业范例（42家知名企业）

Abbott Cardiovascular
Biotronik SE & Co. KG
Boston Scientific Corporation
EBR Systems, Inc.
Lepu Medical Technology（Beijing）Co., Ltd.
LivaNova PLC
Medico SpA
Medtronic Plc
MicroPort Scientific Corporation
Osypka Medical GmbH

The global market for Cardiac Resynchronization Therapy (CRT) Devices estimated at US$6.5 Billion in the year 2023, is expected to reach US$10.9 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. CRT-Defibrillator (CRT-D), one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$7.8 Billion by the end of the analysis period. Growth in the CRT-Pacemaker (CRT-P) segment is estimated at 8.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.8 Billion While China is Forecast to Grow at 7.3% CAGR

The Cardiac Resynchronization Therapy (CRT) Devices market in the U.S. is estimated at US$1.8 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2030 trailing a CAGR of 7.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.0% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.2% CAGR.

Global Cardiac Resynchronization Therapy (CRT) Devices Market - Key Trends and Drivers Summarized

What Are Cardiac Resynchronization Therapy (CRT) Devices and Why Are They Essential?

Cardiac Resynchronization Therapy (CRT) devices are critical tools in the management of heart failure, particularly for patients suffering from electrical conduction problems that impair the heart’s ability to beat efficiently. These devices are designed to restore the coordinated contraction of the heart's ventricles, improving its overall pumping efficiency. CRT devices typically consist of a pacemaker or an implantable cardioverter-defibrillator (ICD) equipped with leads that are placed in both ventricles of the heart. By delivering synchronized electrical pulses to the ventricles, CRT devices correct the misalignment in heartbeats that is common in patients with heart failure or bundle branch block. This form of therapy is often prescribed for individuals who have moderate to severe heart failure and who have not responded well to conventional treatments. The ultimate goal of CRT is to reduce the symptoms of heart failure, such as shortness of breath and fatigue, improve the quality of life, and lower the risk of hospitalization or death. With heart failure affecting millions of people worldwide, CRT devices represent a vital intervention in the management of this chronic and often debilitating condition.

How Is Technology Enhancing the Effectiveness of CRT Devices?

The technological evolution of CRT devices has significantly enhanced their effectiveness, safety, and the overall patient experience. One of the key advancements in this field has been the development of adaptive CRT systems that automatically adjust pacing based on a patient’s activity levels and heart rhythms. These systems utilize sophisticated algorithms to optimize therapy by ensuring the heart beats as efficiently as possible under various conditions, such as rest or exercise. Another major innovation is the integration of remote monitoring capabilities, allowing real-time transmission of patient data to healthcare providers. This enables clinicians to continuously monitor the performance of the device and the patient's heart condition without the need for frequent in-person visits. Remote monitoring not only improves patient outcomes through timely adjustments in therapy but also reduces the need for hospitalizations and emergency interventions. Additionally, the miniaturization of CRT devices has made them less invasive and more comfortable for patients. These smaller, more efficient devices now have longer battery lives and are easier to implant, reducing the risk of complications during surgery. The inclusion of wireless technology in CRT devices has further improved patient care, allowing for seamless communication between the device and external monitoring systems. As technology continues to advance, the precision and efficacy of CRT devices in treating heart failure are expected to grow, offering even better outcomes for patients.

What Are the Key Market Trends in Cardiac Resynchronization Therapy Devices?

Several important trends are driving the cardiac resynchronization therapy devices market, shaped by advancements in technology, demographic shifts, and changes in healthcare delivery. One of the most notable trends is the increasing prevalence of heart failure globally, largely driven by aging populations and the rising incidence of conditions such as hypertension, diabetes, and coronary artery disease, all of which contribute to the onset of heart failure. This has fueled the demand for CRT devices as a treatment option for patients who are not responding to medications alone. Another key trend is the growing adoption of remote patient monitoring solutions. With healthcare systems increasingly moving towards digital platforms, CRT devices with remote monitoring capabilities are becoming more widespread. This not only improves patient management but also aligns with the global trend towards telemedicine and home-based care. Furthermore, the ongoing miniaturization of CRT devices and the development of leadless versions are set to revolutionize the market by making the devices less invasive and reducing the potential for lead-related complications. Regulatory approval of these innovative devices is accelerating, particularly in developed regions like North America and Europe, where regulatory agencies have streamlined processes to get these life-saving technologies to patients faster. Lastly, the expansion of healthcare coverage and reimbursement policies in several regions is making CRT devices more accessible to a broader patient population, driving increased adoption.

What Are the Factors Driving Expansion of the CRT Devices Market?

The growth in the cardiac resynchronization therapy devices market is driven by several key factors tied to advancements in technology, shifts in healthcare trends, and changing patient demographics. A primary driver is the rising prevalence of heart failure across the globe, particularly in aging populations. As the number of heart failure patients continues to increase, so does the demand for effective treatment options like CRT, which is especially critical for patients who do not respond to conventional heart failure therapies. The ongoing advancements in CRT technology, such as the development of adaptive CRT devices and the integration of remote monitoring capabilities, have significantly enhanced the appeal of these devices. Adaptive systems that automatically adjust pacing parameters based on patient-specific needs improve therapy effectiveness and reduce the likelihood of complications. Moreover, the widespread adoption of telemedicine and remote patient monitoring has boosted the demand for CRT devices that can seamlessly transmit data, allowing for more proactive and efficient management of heart failure patients. The shift toward home-based care, further accelerated by the COVID-19 pandemic, has emphasized the importance of remote monitoring in chronic disease management. Another driver is the increasing focus on reducing hospital readmissions and improving long-term outcomes, which has led healthcare systems to embrace value-based care models. CRT devices, by improving heart function and reducing the need for emergency interventions, align well with these healthcare goals. Additionally, advancements in device miniaturization and battery life are making CRT devices more accessible, less invasive, and more durable, leading to higher patient satisfaction and better overall adoption. Finally, favorable regulatory policies and expanding healthcare coverage, especially in developed markets, have made it easier for patients to access these life-saving devices, further fueling market growth.

Select Competitors (Total 42 Featured) -

Abbott Cardiovascular
Biotronik SE & Co. KG
Boston Scientific Corporation
EBR Systems, Inc.
Lepu Medical Technology (Beijing) Co., Ltd.
LivaNova PLC
Medico SpA
Medtronic Plc
MicroPort Scientific Corporation
Osypka Medical GmbH

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- Global Economic Update
- Cardiac Resynchronization Therapy (CRT) Devices - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
- Rising Incidence of Heart Failure Throws the Spotlight on Cardiac Resynchronization Therapy (CRT) Devices
- Technological Advancements in CRT Devices Propel Growth in Heart Failure Treatment
- Increasing Use of Remote Monitoring Expands Addressable Market Opportunity for CRT Devices
- Growing Adoption of AI in Health Monitoring Spurs Demand for Smarter CRT Devices
- Integration of Telemedicine Generates New Opportunities for CRT Device Management
- Expanding Use of Advanced Imaging Techniques Drives Precision in CRT Device Implantation
- Rising Demand for Non-Invasive Monitoring Propels Growth in CRT Device Usage
- Innovations in Battery Longevity and Device Miniaturization Accelerate Demand for Next-Generation CRT Devices
- Increasing Need for Long-Term, Real-Time Monitoring Spurs Use of Advanced CRT Devices
- Advancements in Device Connectivity and Data Analytics Propel Growth of CRT Solutions
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Cardiac Resynchronization Therapy (CRT) Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 3: World Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 4: World 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for CRT-Defibrillator (CRT-D) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 6: World Historic Review for CRT-Defibrillator (CRT-D) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 7: World 16-Year Perspective for CRT-Defibrillator (CRT-D) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for CRT-Pacemaker (CRT-P) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 9: World Historic Review for CRT-Pacemaker (CRT-P) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 10: World 16-Year Perspective for CRT-Pacemaker (CRT-P) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Hospitals & Cardiac Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 12: World Historic Review for Hospitals & Cardiac Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 13: World 16-Year Perspective for Hospitals & Cardiac Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 16: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

UNITED STATES
- Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- TABLE 17: USA Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 18: USA Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 19: USA 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
- TABLE 20: USA Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 21: USA Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 22: USA 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
CANADA
- TABLE 23: Canada Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 24: Canada Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 25: Canada 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
- TABLE 26: Canada Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 27: Canada Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 28: Canada 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
JAPAN
- Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- TABLE 29: Japan Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 30: Japan Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 31: Japan 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
- TABLE 32: Japan Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 33: Japan Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 34: Japan 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
CHINA
- Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- TABLE 35: China Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 36: China Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 37: China 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
- TABLE 38: China Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 39: China Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 40: China 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
EUROPE
- Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- TABLE 41: Europe Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- TABLE 42: Europe Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 43: Europe 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
- TABLE 44: Europe Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 45: Europe Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 46: Europe 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
- TABLE 47: Europe Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 48: Europe Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 49: Europe 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
FRANCE
- Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- TABLE 50: France Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 51: France Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 52: France 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
- TABLE 53: France Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 54: France Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 55: France 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
GERMANY
- Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- TABLE 56: Germany Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 57: Germany Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 58: Germany 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
- TABLE 59: Germany Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 60: Germany Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 61: Germany 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
ITALY
- TABLE 62: Italy Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 63: Italy Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 64: Italy 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
- TABLE 65: Italy Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 66: Italy Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 67: Italy 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- TABLE 68: UK Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 69: UK Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 70: UK 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
- TABLE 71: UK Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 72: UK Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 73: UK 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
REST OF EUROPE
- TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 75: Rest of Europe Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 76: Rest of Europe 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
- TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 78: Rest of Europe Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 79: Rest of Europe 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Cardiac Resynchronization Therapy (CRT) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 81: Asia-Pacific Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 82: Asia-Pacific 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
- TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 84: Asia-Pacific Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 85: Asia-Pacific 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
REST OF WORLD
- TABLE 86: Rest of World Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 87: Rest of World Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by Segment - CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 88: Rest of World 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by Segment - Percentage Breakdown of Value Sales for CRT-Defibrillator (CRT-D) and CRT-Pacemaker (CRT-P) for the Years 2014, 2024 & 2030
- TABLE 89: Rest of World Recent Past, Current & Future Analysis for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- TABLE 90: Rest of World Historic Review for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Hospitals & Cardiac Centers and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- TABLE 91: Rest of World 16-Year Perspective for Cardiac Resynchronization Therapy (CRT) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Cardiac Centers and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030